Report cover image

Global Ibuprofen API Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20359426

Description

Summary

According to APO Research, the global Ibuprofen API market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Ibuprofen API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Ibuprofen API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Ibuprofen API market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Ibuprofen API is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Ibuprofen API market include Shandong Xinhua Pharmaceutical, Biocause, SOLARA, SI Group, IOLCP and BASF, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ibuprofen API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Ibuprofen API, also provides the sales of main regions and countries. Of the upcoming market potential for Ibuprofen API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ibuprofen API sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Ibuprofen API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Ibuprofen API sales, projected growth trends, production technology, application and end-user industry.

Ibuprofen API Segment by Company

Shandong Xinhua Pharmaceutical
Biocause
SOLARA
SI Group
IOLCP
BASF
Ibuprofen API Segment by Type

USP
EP
Ibuprofen API Segment by Application

Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Ibuprofen API Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Ibuprofen API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Ibuprofen API market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Ibuprofen API significant trends, drivers, influence factors in global and regions.
6. To analyze Ibuprofen API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ibuprofen API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ibuprofen API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ibuprofen API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ibuprofen API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ibuprofen API industry.
Chapter 3: Detailed analysis of Ibuprofen API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Ibuprofen API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Ibuprofen API in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Ibuprofen API Sales Value (2020-2031)
1.2.2 Global Ibuprofen API Sales Volume (2020-2031)
1.2.3 Global Ibuprofen API Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Ibuprofen API Market Dynamics
2.1 Ibuprofen API Industry Trends
2.2 Ibuprofen API Industry Drivers
2.3 Ibuprofen API Industry Opportunities and Challenges
2.4 Ibuprofen API Industry Restraints
3 Ibuprofen API Market by Company
3.1 Global Ibuprofen API Company Revenue Ranking in 2024
3.2 Global Ibuprofen API Revenue by Company (2020-2025)
3.3 Global Ibuprofen API Sales Volume by Company (2020-2025)
3.4 Global Ibuprofen API Average Price by Company (2020-2025)
3.5 Global Ibuprofen API Company Ranking (2023-2025)
3.6 Global Ibuprofen API Company Manufacturing Base and Headquarters
3.7 Global Ibuprofen API Company Product Type and Application
3.8 Global Ibuprofen API Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Ibuprofen API Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Ibuprofen API Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Ibuprofen API Market by Type
4.1 Ibuprofen API Type Introduction
4.1.1 USP
4.1.2 EP
4.2 Global Ibuprofen API Sales Volume by Type
4.2.1 Global Ibuprofen API Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Ibuprofen API Sales Volume by Type (2020-2031)
4.2.3 Global Ibuprofen API Sales Volume Share by Type (2020-2031)
4.3 Global Ibuprofen API Sales Value by Type
4.3.1 Global Ibuprofen API Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Ibuprofen API Sales Value by Type (2020-2031)
4.3.3 Global Ibuprofen API Sales Value Share by Type (2020-2031)
5 Ibuprofen API Market by Application
5.1 Ibuprofen API Application Introduction
5.1.1 Contract Manufacturing Organizations
5.1.2 Pharmaceutical Companies
5.1.3 Others
5.2 Global Ibuprofen API Sales Volume by Application
5.2.1 Global Ibuprofen API Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Ibuprofen API Sales Volume by Application (2020-2031)
5.2.3 Global Ibuprofen API Sales Volume Share by Application (2020-2031)
5.3 Global Ibuprofen API Sales Value by Application
5.3.1 Global Ibuprofen API Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Ibuprofen API Sales Value by Application (2020-2031)
5.3.3 Global Ibuprofen API Sales Value Share by Application (2020-2031)
6 Ibuprofen API Regional Sales and Value Analysis
6.1 Global Ibuprofen API Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Ibuprofen API Sales by Region (2020-2031)
6.2.1 Global Ibuprofen API Sales by Region: 2020-2025
6.2.2 Global Ibuprofen API Sales by Region (2026-2031)
6.3 Global Ibuprofen API Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Ibuprofen API Sales Value by Region (2020-2031)
6.4.1 Global Ibuprofen API Sales Value by Region: 2020-2025
6.4.2 Global Ibuprofen API Sales Value by Region (2026-2031)
6.5 Global Ibuprofen API Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Ibuprofen API Sales Value (2020-2031)
6.6.2 North America Ibuprofen API Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Ibuprofen API Sales Value (2020-2031)
6.7.2 Europe Ibuprofen API Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Ibuprofen API Sales Value (2020-2031)
6.8.2 Asia-Pacific Ibuprofen API Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Ibuprofen API Sales Value (2020-2031)
6.9.2 South America Ibuprofen API Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Ibuprofen API Sales Value (2020-2031)
6.10.2 Middle East & Africa Ibuprofen API Sales Value Share by Country, 2024 VS 2031
7 Ibuprofen API Country-level Sales and Value Analysis
7.1 Global Ibuprofen API Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Ibuprofen API Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Ibuprofen API Sales by Country (2020-2031)
7.3.1 Global Ibuprofen API Sales by Country (2020-2025)
7.3.2 Global Ibuprofen API Sales by Country (2026-2031)
7.4 Global Ibuprofen API Sales Value by Country (2020-2031)
7.4.1 Global Ibuprofen API Sales Value by Country (2020-2025)
7.4.2 Global Ibuprofen API Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Ibuprofen API Sales Value Growth Rate (2020-2031)
7.5.2 USA Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Ibuprofen API Sales Value Growth Rate (2020-2031)
7.6.2 Canada Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Ibuprofen API Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Ibuprofen API Sales Value Growth Rate (2020-2031)
7.8.2 Germany Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Ibuprofen API Sales Value Growth Rate (2020-2031)
7.9.2 France Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.9.3 France Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Ibuprofen API Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Ibuprofen API Sales Value Growth Rate (2020-2031)
7.11.2 Italy Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Ibuprofen API Sales Value Growth Rate (2020-2031)
7.12.2 Spain Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Ibuprofen API Sales Value Growth Rate (2020-2031)
7.13.2 Russia Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Ibuprofen API Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Ibuprofen API Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Ibuprofen API Sales Value Growth Rate (2020-2031)
7.16.2 China Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.16.3 China Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Ibuprofen API Sales Value Growth Rate (2020-2031)
7.17.2 Japan Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Ibuprofen API Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Ibuprofen API Sales Value Growth Rate (2020-2031)
7.19.2 India Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.19.3 India Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Ibuprofen API Sales Value Growth Rate (2020-2031)
7.20.2 Australia Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Ibuprofen API Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Ibuprofen API Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Ibuprofen API Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Ibuprofen API Sales Value Growth Rate (2020-2031)
7.24.2 Chile Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Ibuprofen API Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Ibuprofen API Sales Value Growth Rate (2020-2031)
7.26.2 Peru Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Ibuprofen API Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Ibuprofen API Sales Value Growth Rate (2020-2031)
7.28.2 Israel Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Ibuprofen API Sales Value Growth Rate (2020-2031)
7.29.2 UAE Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Ibuprofen API Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Ibuprofen API Sales Value Growth Rate (2020-2031)
7.31.2 Iran Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Ibuprofen API Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Ibuprofen API Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Ibuprofen API Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Ibuprofen API Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Shandong Xinhua Pharmaceutical
8.1.1 Shandong Xinhua Pharmaceutical Comapny Information
8.1.2 Shandong Xinhua Pharmaceutical Business Overview
8.1.3 Shandong Xinhua Pharmaceutical Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.1.4 Shandong Xinhua Pharmaceutical Ibuprofen API Product Portfolio
8.1.5 Shandong Xinhua Pharmaceutical Recent Developments
8.2 Biocause
8.2.1 Biocause Comapny Information
8.2.2 Biocause Business Overview
8.2.3 Biocause Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.2.4 Biocause Ibuprofen API Product Portfolio
8.2.5 Biocause Recent Developments
8.3 SOLARA
8.3.1 SOLARA Comapny Information
8.3.2 SOLARA Business Overview
8.3.3 SOLARA Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.3.4 SOLARA Ibuprofen API Product Portfolio
8.3.5 SOLARA Recent Developments
8.4 SI Group
8.4.1 SI Group Comapny Information
8.4.2 SI Group Business Overview
8.4.3 SI Group Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.4.4 SI Group Ibuprofen API Product Portfolio
8.4.5 SI Group Recent Developments
8.5 IOLCP
8.5.1 IOLCP Comapny Information
8.5.2 IOLCP Business Overview
8.5.3 IOLCP Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.5.4 IOLCP Ibuprofen API Product Portfolio
8.5.5 IOLCP Recent Developments
8.6 BASF
8.6.1 BASF Comapny Information
8.6.2 BASF Business Overview
8.6.3 BASF Ibuprofen API Sales, Value and Gross Margin (2020-2025)
8.6.4 BASF Ibuprofen API Product Portfolio
8.6.5 BASF Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Ibuprofen API Value Chain Analysis
9.1.1 Ibuprofen API Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Ibuprofen API Sales Mode & Process
9.2 Ibuprofen API Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Ibuprofen API Distributors
9.2.3 Ibuprofen API Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.